Genpharmasec Renames Middle East Subsidiary Pursuant to Revised DMCC Naming Regulations
Genpharmasec Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 8:22 pm
Genpharmasec Renames Middle East Subsidiary Pursuant to Revised DMCC Naming Regulations Genpharmasec Limited has changed the name of its subsidiary from GENPHARMASEC MIDDLE EAST DMCC to GENPHARMASEC MIDDLE EAST FZCO, effective 9th Oct'26. The modification was executed in compliance with updated naming conventions mandated by the Dubai Multi Commodities Centre (DMCC), requiring all registered entities to adopt the suffix "FZCO".
Original exchange filing (PDF)
More announcements from Genpharmasec Ltd
- Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September, 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... 路 03 Nov 2026
- Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026. 路 30 Sept 2026
- Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026. 路 29 Sept 2026
- Annual Report for Financial Year 2025-26. 路 07 Sept 2026
